<DOC>
	<DOCNO>NCT01091012</DOCNO>
	<brief_summary>The main objective validate safety efficacy intravenous oral sildenafil acute vasodilator test patient persistence , least , moderate pulmonary hypertension valvular surgery successfully , correct leave ventricular function valvular disease hemodynamically significant .</brief_summary>
	<brief_title>Effectiveness Vasodilator Test With Revatio , Made Patients With Acute Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Vasodilator Agents</mesh_term>
	<criteria>Patients clinically stable , least 1 year completion successful valve surgery , persistent pulmonary artery systolic pressure &gt; 50 mmHg , normal leave ventricular function significant valvular disease 2 separate Doppler ultrasound study least 1 month . Patients cardiac noncardiac disease exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>